Contract 75N93022C00054
University Of California Irvine · Department Of Health And Human Services · August 9, 2024
University Of California Irvine was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 9, 2024 for $2.13 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Irvine, CA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost no fee contract pricing. The most recent modification was on September 19, 2025. If all options are exercised, the contract could reach $10.23 million.
Contract details
- PIID
- 75N93022C00054
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Irvine, CA
- First action
- August 9, 2024
- Latest action
- September 19, 2025
Description
EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: [ADJUVANT COMPARISON AND CHARACTERIZATION]
Modification timeline
-
September 19, 2025Mod P00012 · Change Order$10.23M
-
August 28, 2025Mod P00011 · Other Administrative ActionADJUVANT COMPARISON AND CHARACTERIZATION$8.76M
-
August 9, 2024Mod P00008 · Change OrderADJUVANT COMPARISON AND CHARACTERIZATION$8.36M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93022C00054?
Contract 75N93022C00054 is a federal contract awarded to University Of California Irvine by Department Of Health And Human Services on August 9, 2024 for $2.13 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93022C00054?
University Of California Irvine won contract 75N93022C00054 from Department Of Health And Human Services.
How much is contract 75N93022C00054 worth?
Contract 75N93022C00054 has obligated $2.13 million to date, with a total potential value of $10.23 million if all options are exercised.